CVRM TA Lead Emerging portfolio

CVRM TA Lead Emerging portfolioABOUT ASTRAZENECA

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.

Join a high-performing team, empowered to cut through the noise and drive real change. Our agility and pace, coupled with scientific focus, powers us to spot opportunities in the market that keep us moving forward and into new spaces.

AstraZeneca is experiencing a significant transformation in the Kingdom of Saudi Arabia, driven by a commitment to advancing healthcare, innovation, and sustainable growth. Building on our global legacy, AZ KSA is rapidly evolving its operations to better serve patients, collaborate with healthcare stakeholders, and contribute to the ambitious goals outlined in the Saudi Vision 2030. We are investing in talent, digital solutions, and new ways of working;

all designed to enhance our impact on patient outcomes and reinforce our leadership in therapeutic areas. This dynamic environment calls for visionary, agile professionals who thrive in change and are motivated to help shape the future of healthcare in KSA.

Our continuous mission is to transform the lives of people living with Chronic non communicable disease, through the development and delivery of innovative medicine, as well as supportive technologies and healthcare services.

In the Saudi Arabia we are building up a dedicated AZ Bio Pharma Business Unit (AZ BBU) to support the Millions of patients suffering from conditions in therapy areas like Cardiovascular, Renal and Metabolisom

As we continue to strenghthen our leadship position and acelerate our new pipeline launching , we seek a CVRM Emerging portfolio Lead to join our Medical Affairs team in Kingdom of Saudi Arabia .

The CVRM Emerging portfolio

Medical Lead reports to the KSA BBU Medical Director and member of the KSA BBU Medical Affairs Leadership team..

The Medical Lead will provide medical affairs therapeutic area leadership to deploy and adapt the AZ Global  International Dyslipidemia , Weight management, and Amyloidosis Medical Affairs strategy, and will lead in future a team of medical affairs professionals (MSLs and Medical Advisors ) and oversees execution of medical activities.

• Providing strategic guidance to building TA medical organisation, creating the TA medical vision and ambition aligned with AZ KSA Vision 2030, working closely with the Medical Director.
• Building and providing leadership to a high-performing KSA BBU medical team (including field medical) with demonstrated value and impact, nurture culture of mentoring and coaching of team members and integrate seamlessly work of medical team with BBU cross-functional brand teams’ efforts.
• Leadership to building of AZ’s External TA leadership, advocacy and establishing enduring partnerships and collaborations with key medical institutions, clinics and research centres and thought leader networks across KSA.
• Responsible for all Emerging portfolio (Weight management , Dyslipidemia and Amyloidosis) TA medical operational and medical compliance processes are in place and driving process development and integration with the KSA AZ applicable policies and procedures.
• The BBU Medical Lead is accountable for the medical team and their activities are conducted in full compliance with all applicable governing local laws and regulations and in compliance with all AZ applicable global and KSA policies, SOPs and guidance.
• Driving patient centric approach to all activities: developing collaborations with Patient Association Groups (PAGs), elevating the awareness/profile of the designated disease area, partnering with HCP’s and PAGs on patient identification initiatives that can be locally adapted. Providing subject matter and medical expertise in areas such as presentation review, abstracts & publications, advisory boards, continuous medical education activities.
• Oversight and development of evidence generation strategy and concepts based…